Fund Holdings — Vida Ventures Advisors, LLC

Total Portfolio Value:
$13.64M
Total Bought:
$0
Total Sold:
$122.95M
Net Transaction:
-$122.95M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Kyverna Therapeutics, Inc.(KYTX)4,523,9244,523,9240$16.92M$8.73M64.02%-$8.19M
Allogene Therapeutics, Inc.1,798,1631,798,1630$3.83M$2.63M19.25%-$1.20M
Kronos Bio, Inc.2,765,3142,765,3140$2.63M$2.28M16.73%-$345.7K
Centessa Pharmaceuticals plc3,931,8180-3,931,818$65.86M$0—-$65.86M
Dyne Therapeutics, Inc.(DYN)407,4990-407,499$9.60M$0—-$9.60M
Tectonic Therapeutic, Inc.(TECX)1,028,6740-1,028,674$47.49M$0—-$47.49M
Page 1 of 1
Vida Ventures Advisors, LLC — 13F Holdings — Q1 2025 | TickerTrail